HomeCompareRTOKY vs PFE

RTOKY vs PFE: Dividend Comparison 2026

RTOKY yields 25.16% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RTOKY wins by $124204617.14M in total portfolio value
10 years
RTOKY
RTOKY
● Live price
25.16%
Share price
$25.58
Annual div
$6.43
5Y div CAGR
95.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124204617.19M
Annual income
$123,042,838,651,506.42
Full RTOKY calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — RTOKY vs PFE

📍 RTOKY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRTOKYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RTOKY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RTOKY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RTOKY
Annual income on $10K today (after 15% tax)
$2,138.27/yr
After 10yr DRIP, annual income (after tax)
$104,586,412,853,780.45/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, RTOKY beats the other by $104,586,412,830,651.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RTOKY + PFE for your $10,000?

RTOKY: 50%PFE: 50%
100% PFE50/50100% RTOKY
Portfolio after 10yr
$62102308.62M
Annual income
$61,521,419,339,358.48/yr
Blended yield
99.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

RTOKY
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RTOKY buys
0
PFE buys
0
No recent congressional trades found for RTOKY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRTOKYPFE
Forward yield25.16%6.20%
Annual dividend / share$6.43$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR95.8%13.2%
Portfolio after 10y$124204617.19M$51.1K
Annual income after 10y$123,042,838,651,506.42$27,210.54
Total dividends collected$124127370.01M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RTOKY vs PFE ($10,000, DRIP)

YearRTOKY PortfolioRTOKY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$15,626$4,925.57$9,161$701.38+$6.5KRTOKY
2$30,803$14,083.85$8,610$859.79+$22.2KRTOKY
3$83,765$50,805.46$8,366$1,081.25+$75.4KRTOKY
4$342,445$252,816.47$8,483$1,405.66+$334.0KRTOKY
5$2,257,727$1,891,310.94$9,084$1,907.24+$2.25MRTOKY
6$25,233,504$22,817,736.25$10,418$2,732.78+$25.22MRTOKY
7$493,667,401$466,667,551.91$13,007$4,193.56+$493.65MRTOKY
8$17,235,028,992$16,706,804,872.08$18,010$7,005.87+$17235.01MRTOKY
9$1,085,774,336,014$1,067,332,854,993.20$28,216$12,979.89+$1085774.31MRTOKY
10$124,204,617,191,042$123,042,838,651,506.42$51,081$27,210.54+$124204617.14MRTOKY

RTOKY vs PFE: Complete Analysis 2026

RTOKYStock

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial and residential customers. The company also provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and laundering of workwear, uniforms, cleanroom uniforms, and protective equipment. Further, the company installs and services interior and exterior plant displays, flowers, replica foliage, Christmas decorations, and ambient scenting for commercial businesses; offers property care services consisting of damp proofing, property conservation, and woodworm and wood rot treatment; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist industrial cleaning and disinfection services, including the professional and discreet disinfection of areas that have been exposed to bio-hazardous situations, such as crime and trauma scenes, prison cells, void properties, emergency vehicles, and healthcare establishments. Additionally, it offers a range of healthcare waste management services comprising the collection, disposal, and recycling of hazardous and offensive waste produced by businesses and organizations associated with the provision of healthcare; and color-coded sharps disposal bins to deal with various types of waste. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.

Full RTOKY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this RTOKY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RTOKY vs SCHDRTOKY vs JEPIRTOKY vs ORTOKY vs KORTOKY vs MAINRTOKY vs JNJRTOKY vs MRKRTOKY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.